Magnesium sulphate for preventing preterm birth in threatened preterm labour

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 8, 2014, Pages

  Crowther, Caroline A ^a,b   Brown, Julie ^a   Mckinlay, Christopher J D ^a   Middleton, Philippa ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; CELECOXIB; GLUCOSE; INDOMETACIN; KETOROLAC; MAGNESIUM SULFATE; NICARDIPINE; NIFEDIPINE; ORAL REHYDRATION SOLUTION; PLACEBO; PROSTAGLANDIN INHIBITOR; RITODRINE; ROFECOXIB; SODIUM CHLORIDE; TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

ANTEPARTUM HEMORRHAGE; BLINDNESS; BRAIN HEMORRHAGE; CEREBRAL PALSY; CHRONIC LUNG DISEASE; CONFIDENCE INTERVAL; DEVELOPMENTAL DELAY; FETUS DEATH; FETUS RISK; GESTATIONAL AGE; HEART ARREST; HUMAN; HYPOTENSION; INTELLECTUAL IMPAIRMENT; INTENSIVE CARE UNIT; LEUKOMALACIA; MATERNAL DEATH; NAUSEA; NECROTIZING ENTEROCOLITIS; NEONATAL INTENSIVE CARE UNIT; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN INFECTION; NEWBORN MORBIDITY; PERCEPTION DEAFNESS; POSTPARTUM HEMORRHAGE; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SYSTEMATIC REVIEW; TACHYCARDIA; UTERUS CONTRACTION; VOMITING; FEMALE; META ANALYSIS; PREGNANCY; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

FEMALE; FETAL DEATH; HUMANS; MAGNESIUM SULFATE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREMATURE BIRTH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TOCOLYTIC AGENTS; TREATMENT OUTCOME;

EID: 84907164535     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD001060.pub2     Document Type: Review

References (117)

1. Aramayo FJF, Martinez FJ, Rosales CL. Tocolytic therapy with magnesium sulfate and terbutaline for inhibition of premature labour [Terapia tocolitica con sulfato de magnesio y terbutalina para la inhibicion del trabajo de parto pretermino]. Ginecologia y Obstetricia de Mexico 1990;58:265-9.
2. Armson BA, Samuels P, Miller F, Verbalis J, Main EK. Evaluation of maternal fluid dynamics during tocolytic therapy with ritodrine hydrochloride and magnesium sulfate. American Journal of Obstetrics and Gynecology 1992;167:758-65.
3. Asgharnia M, Sobhani A, Omidvar-Jalali Z. Comparison of Mg-sulfate and indomethacin in management of preterm labor. Journal of Gorgan University of Medical Sciences 2002;4(10):7-12.
4. Beall MH, Edgar BW, Paul RM, Smith-Wallace T. A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. American Journal of Obstetrics and Gynecology 1985;153:854-9.
5. Borna S, Saeidi FM. Celecoxib versus magnesium sulfate to arrest preterm labor: randomized trial. Journal of Obstetrics and Gynaecology Research 2007;33(5):631-4.
6. Chau AC, Gabert HA, Miller JM. A prospective comparison of terbutaline and magnesium for tocolysis. Obstetrics and Gynecology 1992;80:847-51.
7. Clavin DK, Bayhi DA, Nolan TE, Rigby FB, Cork RC, Miller JM. Comparison of intravenous magnesium sulfate and nitroglycerin for preterm labour: preliminary data [abstract]. American Journal of Obsterics and Gynecology 1996;174(1 Pt 2):307.
8. Cotton DB, Strassner HT, Hill LM, Schifrin BS, Paul RH. Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study. Journal of Reproductive Medicine 1984;29:92-7.
9. Cox SM, Sherman ML, Leveno KJ. Randomized investigation of magnesium sulfate for prevention of preterm birth. American Journal of Obstetrics and Gynecology 1990;163:767-72.
10. Cox SM, Sherman ML, Leveno KJ. Single-center randomized trial of magnesium sulfate for inhibition of uterine contractions in preterm labor. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 Jan 23-27; Houston, Texas, USA. 1990:39.
11. El-Sayed YY, Riley ET, Holbrook RH, Cohen SE, Chitkara U, Druzin ML. Randomized comparison of intravenous nitroglycerin and magnesium sulfate for treatment of preterm labour. Obstetrics and Gynecology 1999;93:79-83.
12. Floyd RC, McLaughlin BN, Martin RW, Roberts WE, Wiser WL, Morrison JC. Comparison of magnesium and nifedipine for primary tocolysis and idiopathic preterm labor [abstract]. American Journal of Obstetrics and Gynecology 1992;166:446 [SPO Abstract 662].
13. Floyd RC, McLaughlin BN, Perry KG, Martin RW, Sullivan CA, Morrison JC. Magnesium sulfate or nifedipine hydrochloride for acute tocolysis of preterm labor: efficacy and side effects. Journal of Maternal-Fetal Investigation 1995;5:25-9.
14. Fox MD, Allbert JR, McCaul JF, Martin RW, McLaughlin BN, Morrison JC. Neonatal morbidity between 34 and 37 weeks' gestation. Journal of Perinatology 1993;XIII:349-63.
15. Fox MD, McCaul JF, Martin RW, Roberts WE, McLaughlin B, Morrison JC. Neonatal morbidity between 34-37 weeks' gestation. American Journal of Obstetrics and Gynecology 1992;166:360.
16. Glock JL, Morales WJ. Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study. American Journal of Obstetrics and Gynecology 1993;169:960-4.
17. Morales WJ, Glock JL. Efficacy and safety of nifedipine vs magnesium sulfate in the management of preterm labor: a randomized study. American Journal of Obstetrics and Gynecology 1993;168:375 [SPO Abstract 119].
18. Haghighi L. Prevention of preterm delivery: nifedipine or magnesium sulfate. International Journal of Gynecology and Obstetrics 1999;66(3):297-8.
19. Hollander DI, Nagey DA, Pupkin MJ. Magnesium sulfate and ritodrine hydrochloride: a randomized comparison. American Journal of Obstetrics and Gynecology 1987;156:631-7.
20. Klauser CK, Briery CM, Keiser SD, Martin RW, Kosek MA, Morrison JC. Effect of antenatal tocolysis on neonatal outcomes. Journal of Maternal-Fetal and Neonatal Medicine 2012;25(12):2778-81.
21. Klauser CK, Briery CM, Martin RW, Langston L, Magann EF, Morrison JC. A comparison of three tocolytics for preterm labor: a randomized clinical trial. Journal of Maternal-Fetal and Neonatal Medicine 2014;27(8):801-6.
22. Larmon JE, Ross BS, May WL, Dickerson GA, Fischer RG, Morrison JC. Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor. American Journal of Obstetrics and Gynecology 1999;181:1432-7.
23. Lorzadeh N, Kazemirad S, Lorzadrh M, Dehnori A. A comparison of human chorionic gonadotropin with magnesium sulphate in inhibition of preterm labor. Journal of Medical Science 2007;7(4):640-4.
24. Lyell D, Penn A, Caughey A, Kogut E, McLellan L, Adams B, et al.Neonatal outcomes following antenatal magnesium sulfate exposure: follow up from a magnesium vs. nifedipine tocolysis RCT. American Journal of Obstetrics and Gynecology 2009;201(6 Suppl 1):S180-S181.
25. Lyell D, Pullen K, Campbell L, Ching S, Burrs D, Chitkara U, et al.Magnesium sulfate versus nifedipine for acute tocolysis of preterm labor [abstract]. American Journal of Obstetrics and Gynecology 2005;193(6 Suppl):S18.
26. Lyell DJ, Pullen K, Campbell L, Ching S, Druzin ML, Chitkara U, et al.Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor - a randomized controlled trial. Obstetrics and Gynecology 2007;110(1):61-7.
27. Ma L. Magnesium sulfate in prevention of preterm labor. Chung Hua I Hsueh Tsa Chih Taipei 1992;72(3):158-61.
28. McWhorter J, Carlan SJ, O'Leary TD. Rofecoxib versus magnesium sulfate to arrest preterm labor: a randomized double-blind trial. Obstetrics and Gynecology 2002;99(4 Suppl):2S.
29. McWhorter J, Carlan SJ, O'Leary TD, Richichi K, O'Brien WF. Rofecoxib versus magnesium sulfate to arrest preterm labor: a randomized trial. Obstetrics and Gynecology 2004;103:923-30.
30. Miller JM, Keane MWD, Horger EO. A comparison of magnesium sulfate and terbutaline for the arrest of premature labor. International Journal of Gynecology and Obstetrics 1984;22:117-23.
31. Miller JM, Keane MWD, Horger EO. Comparison of magnesium sulfate and terbutaline for the arrest of premature labor. Journal of Reproductive Medicine 1982;27(6):348-51.
32. Lee K-S, Mittendorf R, Besinger R, Gianopoulos J, Pryde P. Mechanisms of mortality in the magnesium and neurologic endpoints trial (Magnet Trial): Papile grade III neonatal intraventricular hemorrhage (IVH). Pediatric Research 2002;51(2 of 2):411A.
33. Lee K-S, Mittendorf R, Besinger R, Gianopoulus J, Pryde P. Correlation between fetal-fetal and maternal-fetal ionized magnesium levels. Pediatric Research 2002;51(2 of 2):314A.
34. Mittendorf R, Bentz L, Borg M, Roizen N. Does exposure to antenatal magnesium sulfate prevent cerebral palsy?. American Journal of Obstetrics and Gynecology 2000;182(1 Pt 2):S20.
35. Mittendorf R, Bentz L, Kohn J, Covert R. Use of antenatal magnesium sulfate does not seem to prevent intraventricular haemorrhage. American Journal of Obstetrics and Gynecology 2000;182(1 Pt 2):S34.
36. Mittendorf R, Covert R, Boman J, Khoshnood B, Lee K-S, Seigler M. Is tocolytic magnesium sulphate associated with increased total paediatric mortality?. Lancet 1997;350:1517-8.
37. Mittendorf R, Covert R, Elin R, Pryde PG, Khoshnood B, Lee K. Umbilical cord serum ionized magnesium level and total pediatric mortality. Obstetrics and Gynecology 2001;98:75-8.
38. Mittendorf R, Dambrosia J, Dammann O, Pryde P, Lee K-S, Ben-Ami T, et al.Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage. Journal of Pediatrics 2002;140:540-6.
39. Mittendorf R, Dambrosia J, Khoshnood B, Lee K-S, Pryde P, Yousefzadeh D. Association between magnesium and intraventricular haemorrhage. American Journal of Obstetrics and Gynecology 2001;184(1):S188.
40. Mittendorf R, Dambrosia J, Khoshnood B, Lee K-S, Pryde P, Yousefzadeh D. Magnesium sulfate is no more efficacious than other tocolytic agents. American Journal of Obstetrics and Gynecology 2001;184(1):S188.
41. Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianopoulos JG, Besinger RE, et al.Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. American Journal of Obstetrics and Gynecology 2002;186(6):1111-8.
42. Mittendorf R, Janeczek S, Macmillan W, Gianopoulos J, Besinger R, Karlman R, et al.Mechanisms of mortality in the magnesium and neurologic endpoints trial (MAGnet trial): fetal inflammatory response syndrome (FIRS). American Journal of Obstetrics and Gynecology 2001;185(6 Suppl):S151.
43. Mittendorf R, Khoshmood B, Pryde P, Lee K-S, Sriram S. Predicting neonatal serum ionized magnesium levels at delivery. Pediatric Research 2001;49(2 of 2):407A.
44. Mittendorf R, Kuban K, Pryde PG, Gianopoulos JG, Yousefzadeh D. Antenatal risk factors associated with the development of lenticulostriate vasculopathy (lsv) in neonates. Journal of Perinatology 2005;25(2):101-7.
45. Mittendorf R, Pryde P. Tocolytic magnesium sulfate: are the epidemiologic data reassuring?. American Journal of Obstetrics and Gynaecology 1998;179(1):280.
46. Mittendorf R, Pryde P, Khoshnood B, Lee K-S. If tocolytic magnesium sulfate is associated with excess total pediatric mortality, what is its impact?. Obstetrics and Gynecology 1998;92(2):308-11.
47. Mittendorf R, Roizen N, Moawad A, Khoshnood B, Lee K-S. Association between cerebral palsy and coagulase-negative staphylococci. Lancet 1999;354:1875-6.
48. Mittendorf R, Stratford R, Khoshnood B, Lee K-S, Pryde P. Persistence of elevated serum magnesium levels in the neonate. American Journal of Obstetrics and Gynaecology 2001;184(1):S50.
49. Morales WJ, Madhav H. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: A randomized study. JAMA 1993;270(22):2676.
50. Morales WJ, Madhav H. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: a randomized study. American Journal of Obstetrics and Gynecology 1993;169:97-102.
51. Morales WJ, Madhav H. Efficacy and safety of indomethacin vs magnesium sulfate in the management of preterm labor: A randomized study. American Journal of Obstetrics and Gynecology 1991;164:280 [SPO Abstract 119].
52. Parilla BV, Tamura RK, Cohen LS, Clark E. Lack of effect of antenatal indomethacin on fetal cerebral blood flow. American Journal of Obstetrics and Gynecology 1997;176(6):1166-9.
53. Parsons MT, Owens CA, Spellacy WN. Thermic effects of tocolytic agents: decreased temperature with magnesium sulfate. Obstetrics and Gynecology 1987;69:88-90.
54. Pezzati M, Giani T, Gambi B, Dani C, Bertini G, Biagiotti R, et al.Influence of maternal magnesium sulphate and ritodrine treatment on cerebral blood flow velocity of the preterm newborn. Acta Obstetricia et Gynecologica Scandinavica 2001;80:818-23.
55. Arda S, Sayin NC, Sut N, Varol FG. The effect of tocolytic agents on maternal and fetal doppler flow patterns in women with preterm labor. Journal of Maternal-Fetal and Neonatal Medicine 2008;21(Suppl 1):22.
56. Sayin NC, Arda S, Varol FG, Sut N. The effects of ritodrine and magnesium sulfate on maternal and fetal Doppler blood flow patterns in women with preterm labor. European Journal of Obstetrics & Gynecology and Reproductive Biology 2010;152:50-4.
57. Schorr SJ, Ascarelli MH, Rust OA, Ross EL, Calfee EF, Perry KG, et al.Ketorolac is a safe and effective drug for acute tocolysis. American Journal of Obstetrics and Gynecology 1997;176(1 Pt 2):S7 [SPO Abstract 16].
58. Schorr SJ, Ascarelli MH, Rust OA, Ross EL, Calfee EL, Perry KG, et al.Comparative study of ketorolac (toradol) and magnesium sulfate for arrest of preterm labor. Southern Medical Journal 1998;91(11):1028-31.
59. Sciscione A, Gorman R, Schlossman P, Colmorgen G. A randomized prospective study of intravenous magnesium sulfate, ritodrine, and subcutaneous terbutaline as treatments for preterm labor. American Journal of Obstetrics and Gynecology 1993;168:376 [SPO Abstract 281].
60. Steer CM, Petrie RH. A comparison of magnesium sulfate and alcohol for the prevention of premature labor. American Journal of Obstetrics and Gynecology 1977;129:1-4.
61. Surichamorn P. The efficacy of terbutaline and magnesium sulfate in the management of preterm labor. Journal of the Medical Association of Thailand 2001;84:98-104.
62. Taherian AA, Dehdar P. Comparison of efficacy and safety of nifedipine versus magnesium sulfate in treatment of preterm labour. Journal of Research in Medical Sciences 2007;12(3):136-42.
63. Tchilinguirian NG, Najem R, Sullivan GB, Craparo FJ. The use of ritodrine and magnesium sulfate in the arrest of premature labor. International Journal of Gynaecology and Obstetrics 1984;22:117-23.
64. Wang H, Zeng W, Liu H, Ou Y. A randomized controlled trial on the treatment of preterm labour with ritodrine hydrochloride and magnesium sulfate. West China University of Medical Sciences 2000;31(4):515-7.
65. Wilkins IA, Lynch L, Mehalek KE, Berkowitz GS, Berkowitz RL. Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents. American Journal of Obstetrics and Gynecology 1988;159:685-9.
66. Zhu B, Fu Y. Treatment of preterm labor with ritodrine. Chung Hua Fu Chan Ko Tsa Chih 1996;31(12):721-3.
67. Behrad V, Moossavifar N, Mojtahedzaden M, Esmalli H, Moghtadeii P. A prospective, randomized, controlled trial of high and low doses of magnesium sulfate for acute tocolysis. Acta Medica Iranica 2003;41(2):126-31.
68. Di Renzo GC, Mignosa M, Gerli S, Burnelli L, Luzi G, Clerici G, et al.The combined maternal administration of magnesium sulfate and aminophylline reduces intraventricular hemorrhage in very preterm neonates. American Journal of Obstetrics and Gynecology 2005;192:433-8.
69. Ferguson JE, Hensleigh PA, Kredenster D. Adjunctive use of magnesium sulfate with ritodrine for preterm labour. American Journal of Obstetrics and Gynecology 1984;148:166-71.
70. Ferguson JE, Holbrook RH, Stevenson DK, Hensleigh PA, Kredentser D. Adjunctive magnesium sulfate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology 1987;156:103-7.
71. Hatjis CG, Swain M, Nelson LH, Meis PJ, Ernest JM. Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor. Obstetrics and Gynecology 1987;69:317-22.
72. Herschel M, Mittendorf R. Case report: Tocolytic magnesium sulfate toxicity and unexpected neonatal death. Journal of Perinatology 2001;21:261-3.
73. How H, Cook C, Cook V, Spinnato J. Preterm premature rupture of membranes: aggressive tocolysis versus expectant management. American Journal of Obstetrics and Gynecology 1996;174:306.
74. How HY, Cook CR, Cook VD, Miles DE, Spinnato JA. Preterm premature rupture of membranes: aggressive tocolysis versus expectant management. Journal of Maternal-Fetal Medicine 1998;7:8-12.
75. How HY, Zafaranchi L, Stella C, Recht K, Maxwell R, Sibai B, et al.Magnesium sulfate (MGSO4) tocolysis versus no tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology 2005;193(6 Suppl):S6.
76. How HY, Zafaranchi L, Stella CL, Recht K, Maxwell RA, Sibai BM, et al.Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study. American Journal of Obstetrics and Gynecology 2006;194:976-81.
77. Ieda K, Sasaki J, Mizuno S, Mimura S, Suzuki C, Miyazaki T, et al.The clinical effects of maternally administered magnesium sulfate on the neonate. Journal of Perinatal Medicine 1991;2:225S.
78. Kara M, Yilmaz E, Avci I, Öge T. Comparison of nifedipine with magnesium sulphate plus terbutaline for the treatment of preterm labor. Journal of the Turkish Society of Obstetrics and Gynecology 2009;6(4):250-6.
79. Mittendorf R, Pryde PG. An overview of the possible relationship between antenatal pharmacologic magnesium and cerebral palsy. Journal of Perinatal Medicine 2000;28:286-93.
80. Ogburn PL, Hansen CA, Williams PP, Butler JC, Joseph MS, Julian TM. Magnesium sulfate and B-mimetic dual-agent tocolysis in preterm labor after single-agent failure. Journal of Reproductive Medicine 1985;30(8):583-7.
81. Pryde PG, Besinger RE, Gianopoulos JG, Mittendorf R. Adverse and beneficial effects of tocolytic therapy. Seminars in Perinatology 2001;25:316-40.
82. Scudiero R, Khoshnood B, Pryde PG, Lee KS, Mittendorf R. Perinatal death and tocolytic magnesium sulfate. Obstetrics and Gynecology 2000;96:178-82.
83. Soguk C, Taoisiz OL, Mungan T. Low dose treatment protocol in magnesium sulfate tocolysis. International Journal of Gynecology and Obstetrics 2004;86:37-8.
84. Terrone DA, Rinehart BK, Kimmel ES, May WL, Larmon JE, Morrison JC. A prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis. American Journal of Obstetrics and Gynecology 2000;182(6):1477-82.
85. Wischnik A, Hettenbach A, Schmidt R, Zieger W, Hug G, Melchert F. The influence of magnesium sulphate on the fluid balance during tocolysis with the betamimetic agent fenoterol. Gynakologische Rundschau 1989;29(2):188-91.
86. Zygmunt M, Heilmann L, Berg C, Wallwiener D, Grischke E, Munstedt K, et al.Local and systemic tolerability of magnesium sulphate for tocolysis. European Journal of Obstetrics & Gynecology and Reproductive Biology 2003;107(2):168-75.
87. Lotfalizadeh M, Teymoori M. Comparison of nifedipine and magnesium sulfate in the treatment of preterm. Iranian Journal of Obstetrics, Gynecology and Infertility 2010; Vol. 13, issue 2.
88. Briery CM. Magnesium sulfate versus placebo for tocolysis in PPROM. ClinicalTrials.gov (http://clinicaltrials.gov) (accessed 8 July 2011) 2011.
89. Sooky Z. Comparison of delaying in premature labour by indomethacin and Mg sulphate in pregnant women referred to maternity hospital. IRCT Iranian Registry of Clinical Trials (www.irct.ir) (accessed 6 December 2010) 2010.
90. American College of Obstetrics and Gynecology. Management of preterm labour: practice bulletin. Obstetrics & Gynecology 2012;119(6):1308-16.
91. American College of Obstetrics and Gynecology. Magnesium sulfate use in obstetrics: committee opinion. Obstetrics & Gynecology 2013;122(3):727-8.
92. Besinger R, Niebyl J. The safety and efficacy of tocolytic agents for the treatment of preterm labour. Obstetrical and Gynecological Survey 1990;45:415-39.
93. Boyle E, Poulsen G, Field D, Kurinczuk J, Wolke D, Alfirevic Z, et al.Effects of gestational age at birth on health outcomes at 3 and 5 years of age: Population based cohort. BMJ 2012;344:e896.
94. Claas MJ, Bruinse HW, van der Heide-Jalving M, Termote J, de Vries LS. Changes in survival and neonatal morbidity in infants with a birthweight of 750g or less. Neonatology 2010;98:278-88.
95. Darlow BA, Mogridge N, Harwood LJ, Wynn-Williams MB, Austin NC. Admisson of all gestations to a regional neonatal unit versus controls: Neonatal morbidity. Journal of Paediatrics and Child Health 2009;45:181-6.
96. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD004661.pub3]
97. Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Systematic Reviews 2010, Issue 11. [DOI: 10.1002/14651858.CD000025.pub2]
98. Greenberg M, Penn A, Thomas L, El-Sayed Y, Caughey A, Lyell D. Neonatal medical admission in a term and late preterm cohort exposed to magnesium sulphate. American Journal of Obstetrics and Gynecology 2011;204(515):e1-7.
99. Grimes DA, Nanda K. Magnesium sulfate tocolysis: time to quit. Obstetrics and Gynecology 2006;108(4):986-9.
100. Haas D, Imperiale T, Kirkpatrick P, Klein R, Zollinger T, Gowchowski A. Tocolytic therapy. A meta-analysis and decision analysis. Obstetrics and Gynecology 2009;113:585-94.
101. Haas DM, Caldwell DM, Kirkparick P, McIntosh JJ, Welton NJ. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 2012;345:e6226.
102. Hall D, McGaughery H Jr, Corey E, Thornton W. The effects of magnesium therapy on the duration of labour. American Journal of Obstetrics and Gynecology 1959;78:27-32.
103. Han S, Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD000940.pub3]
104. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011.
105. Kugelman A, Bader D, Lerner-Geva L, Boyko V, Levitzki O, Riskin A, et al.Poor outcomes at discharge among extremely premature infants: a national population based study. Archives of Pediatrics & Adolescent Medicine 2012;166(6):543-50.
106. Lipsitz PJ. The clinical and biochemical effects of excess magnesium in the newborn. Pediatrics 1971;47:501-9.
107. Howson CP, Kinney MV, Lawn JE (editors). Born Too Soon: The Global Action Report on Preterm Birth. Geneva: World Health Organization, 2012.
108. McDonnell NJ. Cardiopulmonary arrest in pregnancy: two case reports of successful outcomes in association with perimortem caesarian delivery. British Journal of Anaesthesia 2009;103(3):406-9.
109. McIntosh T, Vink R, Yamakami I, Faden A. Magnesium protects against neurological deficit after brain injury. Brain Research 1989;482:252-60.
110. Mildvan AS. Role of magnesium and other divalent cations in ATP-utilizing enzymes. Magnesium 1987;6(1):28-33.
111. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
112. Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004454.pub2]
113. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: 10.1002/14651858.CD001060]
114. Keirse M. Magnesium sulphate in preterm labour. [revised 07 April 1994]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
115. Keirse M. Magnesium sulphate + betamimetics for tocolysis in preterm labour. [revised 07 April 1994]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
116. Keirse M. Magnesium sulphate vs betamimetics for tocolysis in preterm labour. [revised 07 April 1994]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
117. Keirse M. Magnesium sulphate vs ethanol for tocolysis in preterm labour. [revised 07 April 1994]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.